Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-090849
Filing Date
2024-10-25
Accepted
2024-10-25 17:00:39
Documents
10
Period of Report
2024-12-05

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0217586-01.htm DEF 14A 1193335
2 GRAPHIC ttherapeuticsmd_logo.jpg GRAPHIC 38886
3 GRAPHIC tmarlan_sig.jpg GRAPHIC 14305
4 GRAPHIC timage_001.jpg GRAPHIC 21254
5 GRAPHIC timage_002.jpg GRAPHIC 12342
6 GRAPHIC timage_003.jpg GRAPHIC 21198
7 GRAPHIC tbarchart_001.jpg GRAPHIC 547781
8 GRAPHIC tbarchart_002.jpg GRAPHIC 555706
9 GRAPHIC tproxy_001.jpg GRAPHIC 1489260
10 GRAPHIC tproxy_002.jpg GRAPHIC 885819
  Complete submission text file 0001213900-24-090849.txt   6135979
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-00100 | Film No.: 241397743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)